• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 516438 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416835965 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416835965 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Alkermes is Among the Companies in the Biotechnology Industry With the Lowest PEG Ratio (ALKS, UTHR, ANIK)

Published on Wed, 06/12/2013 - 11:15
By Robert Cotter

Below are the three companies in the Biotechnology industry with the lowest price to earnings to growth (PEG) ratios. PEG is valuable in assessing the tradeoff between the price of a stock and expected growth. Generally, the lower the PEG, the better.

Alkermes (NASDAQ:ALKS) is lowest with a PEG ratio of 0.25. Alkermes, Inc. develops products based on drug delivery technologies. The Company is focusing on controlled, sustained release of injectable drugs, as well as the delivery of drugs into the brain past the blood-brain barrier. Alkermes is also focusing on the oral delivery of drugs, and the development of pharmaceutical products based on pulmonary drug delivery technologies.

Alkermes has overhead space with shares priced $30.53, or 1.5% below the average consensus analyst price target of $31.00. Alkermes shares have support at the 50-day moving average (MA) of $29.42 and additional support at the 200-day MA of $22.66.

United Therapeutics (NASDAQ:UTHR) is next with a PEG ratio of 0.46.

Finishing up the bottom three is Anika Therapeutics (NASDAQ:ANIK), with a PEG ratio of 0.74.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

Analysis of Relative Performance in the ...

Analysis was conducted on the Life & Health Insurance industry to measure relative perf ...

Smith & Wesson had the Lowest Relative P...

Here are 5 stocks in the Leisure Products industry ranked by performance. We compiled ...

BGC Partners has Relatively Underperform...

Analysis was conducted on the Investment Banking & Brokerage industry to measure relati ...

Shares of Liquidity Services Underperfor...

Below are five companies in the Internet Software & Services industry that underperform ...

Analysis of Relative Performance in the ...

Analysis was conducted on the Internet Retail industry to measure relative performance ...

Donaldson had the Lowest Relative Perfor...

Here are 5 stocks in the Industrial Machinery industry ranked by performance. We compi ...

Aaron's has Relatively Underperformed it...

Below are five companies in the Homefurnishing Retail industry that underperformed yest ...

Bottom 5 Companies in the Health Care Se...

Here are 5 stocks in the Health Care Services industry ranked by performance. We compi ...